working

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here

More Content

More Content

ADAP 4Q24 Earnings: EPS Miss on 1x Restructuring/Impairment Costs Potential Capital Raise Adds Risk to the Story

Companies: ADAPTIMMUNE THERAPEUTICS-ADR (ADAP:NYSE)Adaptimmune Therapeutics PLC Sponsored ADR (473A:BER)

Scancell, Poolbeg Pharma, Optima Health, SkinBioTherapeutics - Healthcare Week in Review

Companies: Scancell Holdings Plc

ADAP 3Q24 Earnings: Streamlining the Platform Profitability Inflection Point in 2027

Companies: ADAPTIMMUNE THERAPEUTICS-ADR (ADAP:NYSE)Adaptimmune Therapeutics PLC Sponsored ADR (473A:BER)

PANMURE LIBERUM: Scancell Holdings: Increasing SCOPE: More data + Phase 3

Companies: Scancell Holdings Plc

ADAP 2Q24 Earnings: Tecelra FDA Approval + Capital Reload

Companies: ADAPTIMMUNE THERAPEUTICS-ADR (ADAP:NYSE)Adaptimmune Therapeutics PLC Sponsored ADR (473A:BER)

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top